Title: Welcome to Genelux - intro
Description: Not available
Keywords:Genelux, Genelux Corporation, GL-ONC1, GLV-1h68, San Diego, California, Bernried, Germany, Redlands, Genelux GmbH, Research and development, R&D, Product development, Oncolytic virotherapy, Oncolytic viral therapy, Live vector therapy, Live vector-mediated therapy, Immunotherapy, Gene therapy, Biotech, biotechnology, Oncology, Clinical oncology, Virology, Molecular biology,
... (View More)
Microbiology, Genetic engineering, Gene regulation, Gene induction, Bioluminescence, Imaging, Cancer research, Cancer drug, Cancer product, Cancer therapy, Cancer treatment, Cancer clinical trials, Clinical trials Phase I, Clinical trials Phase I/II, Preclinical studies, Preclinical research, Disease targets, Breast cancer, breast tumor, breast metastases, Lung cancer, lung tumor, lung metastases, Mesothelioma, Pancreatic cancer, pancreatic tumor, pancreatic metastases, Liver cancer, Ovarian cancer, Ovarian tumor, Ovarian metastases, Colon cancer, Colon tumor, Colon metastases, Prostate cancer, prostate tumor, prostate metastases, Metastatic cancer, Metastatic tumor, Metastatic metastases, Anaplastic thyroid carcinoma, Anaplastic thyroid cancer, Anaplastic thyroid tumor, Anaplastic thyroid metastases, Solid tumors, Solid metastases, Inflammatory diseases, Mutant virus, genetically-engineered virus, genetically-altered virus, genetically-modified virus, attenuated virus, Bacteria, Microbe, Vaccinia virus, Smallpox vaccine, E. coli Nissle 1917, Renilla luciferase, Green fluorescent protein, GFP, Red fluorescent protein, RFP, Ruc-GFP, RFP-CBG99, Sea pansy, Jellyfish, Fusion protein, Fusion transgene, Fusion payload, Light-emitting protein, glowing protein, Marker gene, Insertion capacity, carrying capacity, tumor therapy(View Less)
